NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Stan, T L ^a   Alvarsson, A ^a   Branzell, N ^a   Sousa, V C ^a   Svenningsson, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; ESKETAMINE; GLUTAMIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR; PHENOL DERIVATIVE; PIPERIDINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICROELECTRODE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; SUBICULUM; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; METABOLISM; PHYSIOLOGY; RANDOMIZATION; SUPPLY AND DISTRIBUTION; ANTIDEPRESSANT ACTIVITY; ELECTRIC POTENTIAL; EVOKED RESPONSE; LIGHT DARK CYCLE;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HIPPOCAMPUS; KETAMINE; MALE; MICE; MICE, INBRED C57BL; MICROELECTRODES; PHENOLS; PIPERIDINES; PREFRONTAL CORTEX; RANDOM ALLOCATION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84901910426     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.39     Document Type: Article

References (45)

1. Kessler RC, Birnbaum HG, Shahly V, Bromet E, Hwang I, McLaughlin KA et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010; 27: 351-364.
2. Schlaepfer TE, Ågren H, Monteleone P, Gasto C, Pitchot W, Rouillon F et al. The hidden third: improving outcome in treatment-resistant depression. Psychopharmacology 2012; 26: 587-602.
3. Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996; 29: 2-11. (Pubitemid 26071332)
4. Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990; 185: 1-10. (Pubitemid 20254891)
5. Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009; 30: 563-569.
6. Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008; 7: 426-437. (Pubitemid 351619114)
7. Ogden KK, Traynelis SF. New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 2011; 32: 726-733.
8. Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007; 10: 1116-1124. (Pubitemid 47339944)
9. Maeng S, Zarate CA Jr., Du J, Schloesser RJ, McCammon J, Chen G et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008; 63: 349-352. (Pubitemid 351146651)
10. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011; 475: 91-95.
11. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H et al. Glutamate N-methyl-Daspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011; 69: 754-761.
12. Muller HK, Wegener G, Liebenberg N, Zarate CA Jr., Popoli M, Elfving B. Ketamine regulates the presynaptic release machinery in the hippocampus. J Psychiatr Res 2013; 47: 892-899.
13. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012; 338: 68-72.
14. Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P et al. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology 2009; 56: 37-46.
15. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959-964.
16. Hascup ER, Hascup KN, Stephens M, Pomerleau F, Huettl P, Gratton A et al. Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem 2010; 115: 1608-1620.
17. Eriksson TM, Alvarsson A, Stan TL, Zhang X, Hascup KN, Hascup ER et al. Bidirectional regulation of emotional memory by 5-HT(1B) receptors involves hippocampal p11. Mol Psychiatry 2012; 18: 1096-1105.
18. Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA. Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 2008; 324: 725-731. (Pubitemid 351185870)
19. Hinzman JM T, Burmeister JJ, Quintero JE, Huettl P, Pomerleau F, Gerhardt GA et al. Diffuse brain injury elevates tonic glutamate levels and potassium evoked glutamate release in discrete brain regions at two days post-injury: an enzymebased microelectrode array study. J Neurotrauma 2010; 27: 889-899.
20. Placantonakis DG, Welsh JP. Two distinct oscillatory states determined by the NMDA receptor in rat inferior olive. J Physiol 2001; 534: 123-140. (Pubitemid 32631761)
21. Fox CJ, Russell KI, Wang YT, Christie BR. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo. Hippocampus 2006; 16: 907-915. (Pubitemid 44857648)
22. Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM, Andreazza AC et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 140-144.
23. Paxinos G Franklin KBJ. The Mouse Brain Atlas in Stereotaxic Coordinates. San Diego: Academic Press, 2001.
24. Stiedl O, Birkenfeld K, Palve M, Spiess J. Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav Brain Res 2000; 116: 157-168.
25. Day BK, Pomerleau F, Burmeister JJ, Huettl P, Gerhardt GA. Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J Neurochem 2006; 96: 1626-1635. (Pubitemid 43351622)
26. Behr J, Wozny C, Fidzinski P, Schmitz D. Synaptic plasticity in the subiculum. Prog Neurobiol 2009; 89: 334-342.
27. Huettl P HE, Hascup KN, Lundblad KM, Stephens ML, Quintero JE et al. Understanding Resting Neurotransmitter Levels in the CNS: Second-by-Second Measurements using Microelectrode Arrays. Poster presentation at the 42nd Annual Winter Conference on Brain Research; Copper Mountain: Colorado, USA, 2009.
28. Nicol B, Rowbotham DJ, Lambert DG. Glutamate uptake is not a major target site for anaesthetic agents. Br J Anaest 1995; 75: 61-65.
29. Illievich UM, Zornow MH, Choi KT, Strnat MAP, Scheller MS. Effects of hypothermia or anesthetics on hippocampal glutamate and glycine concentrations after repeated transient global cerebral ischemia. Anesthesiology 1994; 80: 177-186. (Pubitemid 24033617)
30. Westphalen RI, Desai KM, Hemmings HC Jr. Presynaptic inhibition of the release of multiple major central nervous system neurotransmitter types by the inhaled anaesthetic isoflurane. Br J Anaest 2013; 110: 592-599.
31. Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17: 2921-2927. (Pubitemid 27155025)
32. Kavali ET, Monteggia LM. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 2012; 169: 1150-1156.
33. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L et al. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 2005; 25: 3270-3279. (Pubitemid 40471335)
34. Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS ONE 2010; 5: 8566.
35. Schloesser RJ, Martinowich K, Manji HK. Mood-stabilizing drugs: mechanisms of action. Trends Neurosci 2012; 35: 36-46.
36. O'Mara SM, Commins S, Anderson M. Synaptic plasticity in the hippocampal area CA1-subiculum projection: implications for theories of memory. Hippocampus 2000; 10: 447-456.
37. MacDougall MJ, Howland JG. Acute stress and hippocampal output: exploring dorsal CA1 and subicular synaptic plasticity simultaneously in anesthetized rats. Physiol Rep 2013; 1: e00035.
38. McGuinness L, Taylor C, Taylor RD, Yau C, Langenhan T, Hart ML et al. Presynaptic NMDARs in the hippocampus facilitate transmitter release at theta frequency. Neuron 2010; 68: 1109-1127.
39. Rossi B, Ogden D, Llano I, Tan YP, Marty A, Collin T. Current and calcium responses to local activation of axonal NMDA receptors in developing cerebellar molecular layer interneurons. PLoS ONE 2012; 7: 39983.
40. Buchanan KA, Blackman AV, Moreau AW, Elgar D, Costa RP, Lalanne T et al. Targetspecific expression of presynaptic NMDA receptors in neocortical microcircuits. Neuron 2012; 75: 451-466.
41. Sjöström PJ, Turrigiano GG, Nelson SB. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 2003; 39: 641-654. (Pubitemid 36993581)
42. Chamberlain SE, Yang J, Jones RS. The role of NMDA receptor subtypes in shortterm plasticity in the rat entorhinal cortex. Neural Plast 2008; 872456.
43. Krebs C, Fernandes HB, Sheldon C, Raymond LA, Baimbridge KG. Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. J Neurosci 2003; 23: 3364-3372.
44. Mitterauer BJ. Ketamine may block NMDA receptors in astrocytes causing a rapid antidepressant effect. Front Synaptic Neurosci 2012; 24: 4.
45. Matveeva EA, Price DA, Whiteheart SW, Vanaman TC, Gerhardt GA, Slevin JT. Reduction of vesicle-associated membrane protein 2 expression leads to a kindling-resistant phenotype in a murine model of epilepsy. Neuroscience 2012; 202: 77-86.